Immersive virtual reality as analgesia for women during hysterosalpingography: study protocol for a randomized controlled trial

Wang, Yiling; Gao, Hai-Xiang; Wang, Jin-She; Wang, Jinghui; Zhang, Tingting; Dai, Ya-Liang; Gao, Lulu; Liu, Qiang; Cai, Ju-Min; Yu, Jian‐Qiang; Li, Yuxiang

doi:10.1186/s13063-019-4023-y

Cited by 11 publications

(14 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To our knowledge, this is the first randomised evaluation of feasibility, effectiveness and acceptability of a virtual reality intervention in gynaecology. However, a trial protocol has been published for a randomised controlled trial for VR analgesia for women during hysterosalpingograms and results will be forthcoming 33 …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Virtual reality for acute pain in outpatient hysteroscopy: a randomised controlled trial

Deo

Khan

Mak

et al. 2020

BJOG

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

“…However, a trial protocol has been published for a randomised controlled trial for VR analgesia for women during hysterosalpingograms and results will be forthcoming. 33…”

Section: Strengths and Weaknessesmentioning

confidence: 99%

Virtual reality for acute pain in outpatient hysteroscopy: a randomised controlled trial

Deo

Khan

Mak

et al. 2020

BJOG

View full text Add to dashboard Cite

show abstract

“…[4] [5] [6] [7] Recent literature indicates the successful use of immersive virtual reality (VR) for a variety of painful medical procedures. [8] [9][10] [11][12] [13] Via wearing the VR goggles the user has the illusion of going inside the 3D computer-generated world and visiting novel environments. Immersive VR is hypothesized to reduce pain through distraction, a non-pharmacologic attentional mechanism.…”

Section: Introductionmentioning

confidence: 99%

Immersive Virtual Reality Improves Labor and Delivery Experience for Women: A Randomized Controlled Trial

Carus

Albayrak

Özmen

et al. 2021

Preprint

View full text Add to dashboard Cite

Objective: To evaluate the effectiveness of immersive Virtual Reality (VR) in laboring women on patient satisfaction as a distractive tool and pain relief.Methods: Randomized, controlled clinical trial with 42 laboring women allocated to VR intervention and control groups. Among the VR group, patient satisfaction with the use of VR was assessed by a Virtual Reality Satisfaction Survey and questioning whether they would choose VR in future labor. As a primary outcome patient satisfaction scores regarding the overall labor and delivery experience were compared between the two groups. A secondary outcome was pain assessed by a visual pain rating scale in the early and active phases of labor in both groups. Psychometric information was also collected from participants in each group using Beck Anxiety Inventory and Beck Depression Inventory. Results: We observed a high level of patient satisfaction with the use of immersive VR during labor. The survey revealed a mean satisfaction score of 89.6 ± 10.8 out of a maximum of 100. 20 out of 21 (95%) women in the VR group stated that they would like to use VR again in future labor. VR improved pain scores in early labor and contributed positively to overall labor and delivery experience. The mean pain score pre-VR was 2.6±1.2 compared to 2.0±1.3, post-VR, respectively (p<0.01). Anxiety and depression scores were similar in the intervention and control groups (p=0.103, p=0.13, respectively). Conclusion: Immersive VR application during labor was feasible and associated with higher patient satisfaction based on our study. VR also improved pain scores in early labor before epidural placement. Immersive VR may find a place as an adjunct in Labor and Delivery Units to improve the lengthy labor experience for women. Larger studies are needed to confirm these observations. Trial Registration: ClinicalTrials.gov: NCT05032456 / 02/09/2021https://clinicaltrials.gov/ct2/show/NCT05032456

show abstract

“… Anxiety score. It was collected using a graphic rating scale (GRS) ranging from none (0) to extreme (10) at T0, T1, and T2 [ 19 ]. Physiological parameters.…”

Section: Outcome Measures and Data Collectionmentioning

confidence: 99%

A nitrous oxide/oxygen fixed mixture to reduce pain induced by the hypodermic injection: study protocol for a randomized, controlled trial

Zhang,

Yu,

Dang

et al. 2024

Trials

Self Cite

View full text Add to dashboard Cite

Background Patients with hematological malignancies received multiple hypodermic injections of recombinant human granulocyte colony-stimulating factor. Procedural pain is one of the most common iatrogenic causes of pain in patients with hematological malignancies. It is also identified as the most commonly occurring problem in clinical care in the Department of Hematology and Oncology at Shenzhen University General Hospital. However, providing immediate relief from pain induced by hypodermic injection of recombinant human granulocyte colony-stimulating factor remains a major challenge. This trial aims to evaluate the safety and analgesic efficacy of a fixed nitrous oxide/oxygen mixture for patients with hematological malignancies and experiencing procedural pain caused by hypodermic injection of recombinant human granulocyte colony-stimulating factor in the department. Methods The nitrous oxide/oxygen study is a single-center, randomized, double-blind, placebo-controlled trial involving patients with hematological malignancies who require hypodermic injections of recombinant human granulocyte colony-stimulating factor for treatment. This trial was conducted in the Hematology and Oncology Department of Shenzhen University General Hospital. A total of 54 eligible patients were randomly allocated to either the fixed nitrous oxide/oxygen mixture group (n = 36) or the oxygen group (n = 18). Neither the investigators nor the patients known about the randomization list and the nature of the gas mixture in each cylinder. Outcomes were monitored at the baseline (T0), immediately after hypodermic injection of recombinant human granulocyte colony-stimulating factor (T1), and 5 min after hypodermic injection of recombinant human granulocyte colony-stimulating factor (T2) for each group. The primary outcome measure was the score in the numerical rating scale corresponding to the highest level of pain experienced during hypodermic injection of recombinant human granulocyte colony-stimulating factor. Secondary outcomes included the fear of pain, anxiety score, four physiological parameters, adverse effects, total time of gas administration, satisfaction from both patients and nurses, and the acceptance of the patients. Discussion This study focused on the safety and analgesic efficacy during hypodermic injection of recombinant human granulocyte colony-stimulating factor procedure. Data on the feasibility and safety of nitrous oxide/oxygen therapy was provided if proven beneficial to patients with hematological malignancies during hypodermic injection of recombinant human granulocyte colony-stimulating factor and widely administered to patients with procedural pain in the department. Trial registration Chinese Clinical Trial Register, ChiCTR2200061507. Registered on June 27, 2022. http://www.chictr.org.cn/edit.aspx?pid=170573&htm=4

show abstract

Immersive virtual reality as analgesia for women during hysterosalpingography: study protocol for a randomized controlled trial

Cited by 11 publications

References 37 publications

Virtual reality for acute pain in outpatient hysteroscopy: a randomised controlled trial

Virtual reality for acute pain in outpatient hysteroscopy: a randomised controlled trial

Immersive Virtual Reality Improves Labor and Delivery Experience for Women: A Randomized Controlled Trial

A nitrous oxide/oxygen fixed mixture to reduce pain induced by the hypodermic injection: study protocol for a randomized, controlled trial

Contact Info

Product

Resources

About